Find the correct MBS item number for skin excisions. Select body location, size, and pathology type.
| Area | Defect Size | TCUS | BCC/SCC | Melanoma | Suspected Melanoma |
|---|---|---|---|---|---|
| Area 1 Nose, eyelid, eyebrow, lip, ear, digit, genitalia | <6 mm | 31357 | 31356 | — | 31377 |
| ≥6 mm | 31360 | 31358 | 31371 | 31378 | |
| Area 2 Face, neck, scalp, nipple-areola, distal limb | <14 mm | 31362 | 31361 | 31372 | 31379 |
| ≥14 mm | 31364 | 31363 | 31373 | 31380 | |
| Area 3 Body — everything not Area 1 or 2 | <15 mm | 31366 | 31365 | 31374 | 31381 |
| 15–30 mm | 31368 | 31367 | 31375 | 31382 | |
| >30 mm | 31370 | 31369 | 31376 | 31383 |
TCUS = Tumour, Cyst, Ulcer, Scar. Includes benign lesions — naevi, lipomas, cysts, scars, granulomas.
BCC/SCC items require histology confirmation. If initially excised as TCUS and histology shows malignancy, rebill under the correct BCC/SCC item.
Melanoma items (31371–31376) are for definitive excision of histologically confirmed melanoma, appendageal carcinoma, Merkel cell carcinoma, or malignant connective tissue tumour of skin. There is no item in this range for an Area 1 defect under 6 mm — 31371 requires an excision diameter of 6 mm or more. MBS Book July 2026
Suspected melanoma items (31377–31383) do not require prior histology — used for diagnostic excision biopsy of clinically suspected melanoma.
| Item | Location excised from | Excision diameter |
|---|---|---|
| 31377 | Nose, eyelid, eyebrow, lip, ear, digit or genitalia (or contiguous area) | Less than 6 mm |
| 31378 | Nose, eyelid, eyebrow, lip, ear, digit or genitalia (or contiguous area) | 6 mm or more |
| 31379 | Face, neck, scalp, nipple-areola complex, distal lower limb (distal to and including the knee) or distal upper limb (distal to and including the ulnar styloid) | Less than 14 mm |
| 31380 | Face, neck, scalp, nipple-areola complex or distal limb (as above) | 14 mm or more |
| 31381 | Any part of the body not covered by 31377, 31378, 31379 or 31380 | Less than 15 mm |
| 31382 | Any part of the body not covered by 31377, 31378, 31379 or 31380 | At least 15 mm but not more than 30 mm |
| 31383 | Any part of the body not covered by 31377, 31378, 31379 or 31380 | More than 30 mm |
Each item is defined by both location and excision diameter — the same mapping as the Area 1 / 2 / 3 grid above, listed per item. Items 31381–31383 apply only to sites not covered by 31377–31380, so a lesion on the nose, eyelid, lip, ear, digit or genitalia is never billed under 31383. All of 31377–31383 are not in association with item 45201, except 31378, 31380 and 31383. MBS Book July 2026 · item descriptors, verified 13 Nov 2026
Suspected melanoma items do NOT require histology confirmation before billing (confirmation of malignancy must otherwise be received before itemisation — 31377–31383 are the stated exception). The specimen must still be sent for histological examination.
Histology required: All excision items require the specimen to be sent for histological examination. Malignant items (31356–31376) require histology confirmation before billing (except suspected melanoma 31377–31383).
Benign vs malignant: If histology returns benign, use the benign (even-numbered) item. If you billed as malignant and histology returns benign, you must rebill under the correct item.
Multiple lesions: You can bill separately for each excision if at separate sites. Notate "separate sites" or the location of each on the account.
Healing by secondary intention: Items 31356, 31357, 31358, 31360, 31363, 31364, 31369, 31370, 31371, 31373, 31376, and 31377–31383 allow secondary intention healing. The episode includes all wound management attendances.
Flaps and grafts — co-claiming rules (TN.8.93):
Consultation + excision: You can bill a consultation item (e.g. 23, 36) with an excision item on the same day if the consultation addresses a clinically separate matter.
BCC: 3–4mm clinical margin for well-defined, nodular BCC. Wider for infiltrative or morphoeic subtypes. Refer to Cancer Council Australia Clinical Practice Guidelines for Keratinocyte Cancer.
SCC: 4–6mm for well-differentiated SCC <20mm. Wider margins for larger, poorly differentiated, or high-risk lesions. Refer to Cancer Council guidelines.
Melanoma in situ: 5mm margin.
Melanoma ≤1mm Breslow: 1cm margin.
Melanoma 1–2mm: 1–2cm margin.
Melanoma 2–4mm: 1–2cm margin.
Melanoma >4mm: 2cm margin.
Always refer to the current NHMRC / Cancer Council clinical practice guidelines. Margins are clinical recommendations, not MBS billing requirements — the MBS determines items by defect size, not margin size.
For MBS items 31361–31364 and 31372–31373, the face is defined as the portion of the head anterior to the hairline and above the jawline.
The nose, eyelid, lip, ear, digit, and genitalia have their own items (31356–31360, 31371) and attract higher rebates due to the complexity of excision in these areas.